Related Experiment Videos
APC dosage effects in tumorigenesis and stem cell differentiation
Claudia Gaspar1, Riccardo Fodde
1Dept. of Pathology, Josephine Nefkens Institute, Erasmus University Medical Center, 3000 DR Rotterdam, The Netherlands.
The International Journal of Developmental Biology
|September 7, 2004
Summary
Altered Apc gene function in mice affects stem cell differentiation and tumor susceptibility in a dose-dependent manner, revealing crucial roles for Wnt/beta-catenin signaling in development and disease.
Area of Science:
- Developmental Biology
- Molecular Biology
- Cancer Biology
Background:
- Morphogen gradients are essential for tissue patterning during animal development.
- Wnt, Hedgehog (Hh), and TGF-beta signaling pathways are critical for limb development.
- Differential cellular responses are triggered by varying concentrations of diffusible morphogens.
Purpose of the Study:
- To investigate dosage-dependent Wnt/beta-catenin signaling effects.
- To analyze cellular and phenotypic outcomes of Apc mutations in mice.
- To understand the role of Wnt pathway defects in tumorigenesis.
Main Methods:
- Generation of hypomorphic mutant alleles at the mouse Apc locus.
- Study of stem cell renewal and differentiation.
- Analysis of tumorigenesis in mouse models with Apc mutations.
Main Results:
- Apc mutations differentially impact stem cell differentiation capacity in a dosage-dependent manner.
- Different Apc mutations and Wnt signaling dosages correlate with varying susceptibility to tumorigenesis.
- Tissue-specific beta-catenin thresholds for cell proliferation, differentiation, and apoptosis are proposed.
Conclusions:
- Apc mutations influence stem cell behavior and tumor susceptibility based on Wnt signaling dosage.
- Beta-catenin dosage-dependent effects explain Wnt pathway involvement in tissue homeostasis and tumorigenesis.
- Understanding these mechanisms is key to comprehending tumor initiation and progression.